Literature DB >> 23382401

Diuretic use in black patients with uncontrolled hypertension.

Linda M Gerber1, Samuel J Mann, Margaret V McDonald, Ya-Lin Chiu, Sridevi Sridharan, Penny H Feldman.   

Abstract

BACKGROUND: Highly publicized recommendations favor the use of diuretics as a first-line or add-on agent in the management of hypertension, particularly among black patients and patients with resistant hypertension. Failure to follow such guidelines might contribute to high rates of uncontrolled hypertension. This study assessed diuretic prescribing patterns in a sample of black patients with uncontrolled hypertension who were identified from a population of home care recipients.
METHODS: The study was conducted in an urban home health organization. Participants were black, aged 21 to 80 years, and had a diagnosis of hypertension. Participants with uncontrolled hypertension were identified, and in-home interviewers collected information on prescribed antihypertensive medications.
RESULTS: Of 658 participants, 5.5% were not prescribed any antihypertensives, and only 46% were prescribed a diuretic. Participants who were not taking a diuretic were taking fewer antihypertensive medications (1.7 vs. 2.9; P < 0.0001), had a higher mean diastolic blood pressure (89.2 vs. 85.5; P = 0.0005), and were more likely to have a systolic blood pressure ≥160mm Hg (57.6% vs. 49.0%; P = 0.04). The adjusted mean systolic and diastolic blood pressures were 5 and 4mm Hg lower, respectively, in patients who were taking a diuretic.
CONCLUSIONS: In this sample of black patients with uncontrolled hypertension, despite wide publicizing of the recommendations for use of diuretics, a majority are still not receiving a diuretic. This important issue merits continued attention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23382401      PMCID: PMC3626036          DOI: 10.1093/ajh/hps029

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  23 in total

1.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

2.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

Review 3.  Refractory hypertension.

Authors:  J F Setaro; H R Black
Journal:  N Engl J Med       Date:  1992-08-20       Impact factor: 91.245

4.  Double-blind parallel study of a combination of chlorthalidone 50 mg and triamterene 50 mg in patients with mild and moderate hypertension.

Authors:  D R Spiers; R C Wade
Journal:  Curr Med Res Opin       Date:  1996       Impact factor: 2.580

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.

Authors:  John M Flack; Suzanne Oparil; J Howard Pratt; Barbara Roniker; Susan Garthwaite; Jay H Kleiman; Yonghong Yang; Scott L Krause; Diane Workman; Elijah Saunders
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

7.  Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonists.

Authors:  W Kiowski; F R Bühler; M O Fadayomi; P Erne; F B Müller; U L Hulthén; P Bolli
Journal:  Am J Cardiol       Date:  1985-12-06       Impact factor: 2.778

8.  Optimisation of antihypertensive treatment by crossover rotation of four major classes.

Authors:  J E Dickerson; A D Hingorani; M J Ashby; C R Palmer; M J Brown
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

9.  Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide.

Authors:  H W Schnaper; E D Freis; R G Friedman; W T Garland; W D Hall; J Hollifield; A K Jain; P Jenkins; A Marks; F G McMahon
Journal:  Arch Intern Med       Date:  1989-12

10.  Efficacy of low-dose spironolactone in subjects with resistant hypertension.

Authors:  Mari Konishi Nishizaka; Mohammad Amin Zaman; David A Calhoun
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

View more
  4 in total

1.  Reducing racial and ethnic disparities in hypertension prevention and control: what will it take to translate research into practice and policy?

Authors:  Michael Mueller; Tanjala S Purnell; George A Mensah; Lisa A Cooper
Journal:  Am J Hypertens       Date:  2014-12-12       Impact factor: 2.689

2.  Association of Short Sleep Duration and Atrial Fibrillation.

Authors:  Michael V Genuardi; Rachel P Ogilvie; Aisha Rasool Saand; Rebecca S DeSensi; Melissa I Saul; Jared W Magnani; Sanjay R Patel
Journal:  Chest       Date:  2019-02-27       Impact factor: 9.410

3.  Treatment of hypertension among African Americans: the Jackson Heart Study.

Authors:  Jane Harman; Evelyn R Walker; Vicki Charbonneau; Ermeg L Akylbekova; Cheryl Nelson; Sharon B Wyatt
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-01       Impact factor: 3.738

Review 4.  The highly neglected burden of resistant hypertension in Africa: a systematic review and meta-analysis.

Authors:  Jobert Richie N Nansseu; Jean Jacques N Noubiap; Michel K Mengnjo; Leopold Ndemnge Aminde; Mickael Essouma; Ahmadou M Jingi; Jean Joel R Bigna
Journal:  BMJ Open       Date:  2016-09-20       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.